Switch to:

Strongbridge Biopharma EV-to-EBITDA

: 0.89 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Strongbridge Biopharma's enterprise value is $45.29 Mil. Strongbridge Biopharma's EBITDA for the trailing twelve months (TTM) ended in Jun. 2019 was $50.91 Mil. Therefore, Strongbridge Biopharma's EV-to-EBITDA for today is 0.89.

NAS:SBBP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.9   Max: 3.2
Current: 0.98

-5.9
3.2

During the past 6 years, the highest EV-to-EBITDA of Strongbridge Biopharma was 3.20. The lowest was -5.90. And the median was -2.40.

NAS:SBBP's EV-to-EBITDA is ranked higher than
86% of the 292 Companies
in the Biotechnology industry.

( Industry Median: 14.62 vs. NAS:SBBP: 0.98 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today, Strongbridge Biopharma's stock price is $2.42. Strongbridge Biopharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2019 was $0.45. Therefore, Strongbridge Biopharma's PE Ratio for today is 5.38.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Strongbridge Biopharma EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Strongbridge Biopharma Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBITDA Premium Member Only 0.00 -2.80 -0.06 -2.34 1.66

Strongbridge Biopharma Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.33 -4.47 1.66 2.19 1.64

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Strongbridge Biopharma EV-to-EBITDA Distribution

* The bar in red indicates where Strongbridge Biopharma's EV-to-EBITDA falls into.



Strongbridge Biopharma EV-to-EBITDA Calculation

Strongbridge Biopharma's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=45.293/50.91
=0.89

Strongbridge Biopharma's current Enterprise Value is $45.29 Mil.
Strongbridge Biopharma's EBITDA for the trailing twelve months (TTM) ended in Jun. 2019 was -15.277 (Sep. 2018 ) + 89.244 (Dec. 2018 ) + -16.483 (Mar. 2019 ) + -6.574 (Jun. 2019 ) = $50.91 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Strongbridge Biopharma  (NAS:SBBP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Strongbridge Biopharma's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.42/0.45
=5.38

Strongbridge Biopharma's share price for today is $2.42.
Strongbridge Biopharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2019 was -0.55 (Sep. 2018 ) + 1.64 (Dec. 2018 ) + -0.34 (Mar. 2019 ) + -0.3 (Jun. 2019 ) = $0.45.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Strongbridge Biopharma EV-to-EBITDA Related Terms


Strongbridge Biopharma EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}